Related references
Note: Only part of the references are listed.Real world effectiveness of standard of care triple therapy versus two-drug combinations for treatment of people living with HIV
Ramon Teira et al.
PLOS ONE (2021)
Efficacy and safety of dolutegravir-rilpivirine for maintenance of virological suppression in adults with HIV-1:100-week data from the randomised, open-label, phase 3 SWORD-1 and SWORD-2 studies
Michael Aboud et al.
LANCET HIV (2019)
Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials
Pedro Cahn et al.
LANCET (2019)
Two-drug antiretroviral regimens: an assessment of virologic response and durability among treatment-experienced persons living with HIV in the OPERA® Observational Database
Gerald Pierone et al.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2019)
HIV drug resistance against strand transfer integrase inhibitors
Kaitlin Anstett et al.
RETROVIROLOGY (2017)
Development of a large urban longitudinal HIV clinical cohort using a web-based platform to merge electronically and manually abstracted data from disparate medical record systems: technical challenges and innovative solutions
Alan E. Greenberg et al.
JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION (2016)